文献速递临床免疫质量管理与危急值

意大利1型糖尿病国家筛查计划的实验室诊断工作流程建议

Proposed laboratory diagnostic workflow in the Italian national screening program for type 1 diabetes.
PubMed 文献 · Clin Chem Lab Med · 2026-07-30

本文提出结合区域实验室高通量联合自身抗体检测与国家级参考实验室确认的标准化诊断路径,并讨论协调与质量评估策略。

要点

  • 意大利国家筛查计划拟对5-6岁儿童用毛细血管血和标准化免疫测定法筛查1型糖尿病。
  • proposed工作流程结合区域实验室高通量联合自身抗体检测与中央确认策略。
  • 不一致或不确定样本应转诊至国家参考实验室用替代分析平台检测。

核心结论

  • proposed实验室诊断工作流程可支持意大利基于人群的1型糖尿病筛查的有效实施。

主要发现

  • proposed模型结合区域实验室高通量联合自身抗体检测与基于抗体特异性检测的中央确认策略。
  • 不一致或不确定样本转诊至国家参考实验室采用替代分析平台检测。
  • 确认自身抗体阳性的儿童转诊至儿科糖尿病中心进行代谢分期和纵向监测。

关键数值与推荐

  • 筛查对象为5-6岁儿童,使用毛细血管血样本和标准化免疫测定法。
  • 区域实验室采用高通量联合自身抗体检测,国家参考实验室采用替代分析平台进行确认。

临床怎么用

  • 临床实验室应参与协作研究倡议和国家质量评估计划以确保分析可靠性。
  • 应建立区域与参考实验室之间的标准化诊断路径和整合机制。

局限性

  • 现有国际项目中实验室程序协调、确认检测策略及区域与参考实验室整合仅部分标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Population screening for type 1 diabetes (T1D) using pancreatic islet autoantibodies is increasingly recognized as a promising strategy to reduce diabetic ketoacidosis and identify individuals during the presymptomatic stages of the disease. In Italy, Law 130/2023 and the implementing decree of November 6, 2025 established a national multi-year screening program for T1D and celiac disease in the pediatric population. The program proposes screening of children aged 5-6 years using capillary blood samples and standardized immunometric assays. The implementation of this program will require extensive involvement of clinical laboratories and a standardized diagnostic pathway capable of ensuring analytical reliability, harmonization, and efficient integration between regional and reference centers. The proposed model combines decentralized population screening performed in regional laboratories using high-throughput combined autoantibody assays with a centralized confirmatory strategy based on antibody-specific testing and referral of discordant or inconclusive samples to national reference laboratories employing alternative analytical platforms. Children with confirmed autoantibody positivity are subsequently referred to pediatric diabetes centers for metabolic staging and longitudinal monitoring. Beyond describing the screening pathway, the proposed workflow addresses key challenges that remain only partially standardized in existing international programs, including harmonization of laboratory procedures, confirmatory testing strategies, and integration between regional and reference laboratories. Harmonization strategies, including participation in collaborative research initiatives and national quality assessment programs, will be essential to ensure analytical reliability and support the effective implementation of population-based T1D screening in Italy.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Babini L, Infantino M, Garrafa E, et al. Proposed laboratory diagnostic workflow in the Italian national screening program for type 1 diabetes. Clin Chem Lab Med. 2026. PMID: 42522335. doi:10.1515/cclm-2026-0536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。